1. Show article details.

    Marijuana Stock Movers For August 17, 2022

    Benzinga – 4:34 PM ET 08/17/2022

      This article was generated by Benzinga's automated content engine and reviewed by an editor.

  2. Show article details.

    Bullish Sentiment Across The Cannabis Space - Check Full Movers For August 15, 2022

    Benzinga – 4:45 PM ET 08/15/2022

      This article was generated by Benzinga's automated content engine and reviewed by an editor.

  3. Show article details.

    Recap: 22nd Century Group Q2 Earnings

    Benzinga – 6:26 AM ET 08/09/2022

      22nd Century Group reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 22nd Century Group reported in-line EPS of $-0.06 versus an estimate of $-0.06. Revenue was up $6.11 million from the same period last year.

  4. Show article details.

    BRIEF-22Nd Century Group Reports Q2 Net Loss Per Share Of $0.06

    Reuters – 6:25 AM ET 08/09/2022

    22nd Century Group Inc (XXII): * 22ND CENTURY GROUP REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE SECOND QUARTER 2022. * Q2 SALES ROSE 73 PERCENT TO $14.5 MILLION. * QTRLY NET LOSS WAS $11.5 MILLION, REPRESENTING A NET LOSS PER SHARE OF $0.06. * Q2 EARNINGS PER SHARE VIEW $-0.06 -- REFINITIV IBES DATA Source text for Eikon: Further company coverage:

  5. Show article details.

    22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022

    GlobeNewswire – 6:00 AM ET 08/09/2022

    BUFFALO, N.Y., Aug. 09, 2022 -- 22nd Century Group, Inc. (XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today reported results for the second quarter ended June 30, 2022, and provided an update on recent business highlights.

  6. Show article details.

    Earnings Scheduled For August 9, 2022

    Benzinga – 5:02 AM ET 08/09/2022

      ** Cognition Therapeutics is estimated to report earnings for its second quarter. ** Gilat Satellite Networks is estimated to report quarterly loss at $0.01 per share on revenue of $56.24 million. ** Drive Shack is likely to report quarterly loss at $0.10 per share on revenue of $82.58 million. ** ReWalk Robotics is projected to report earnings for its second quarter.

  7. Show article details.

    Earnings Outlook For 22nd Century Group

    Benzinga – 12:25 PM ET 08/08/2022

      22nd Century Group is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Analysts estimate that 22nd Century Group will report an earnings per share of $-0.06. 22nd Century Group bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

  8. Show article details.

    Bullish Sentiment Across The Cannabis Space - Check Full Movers For August 5, 2022

    Benzinga – 5:24 PM ET 08/05/2022

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

  9. Show article details.

    Cannabis Stock Movers For August 4, 2022

    Benzinga – 4:52 PM ET 08/04/2022

    RIV Capital shares closed down 6.18% at $0.45. This article was generated by Benzinga's automated content engine and reviewed by an editor.

  10. Show article details.

    Video: Understanding Cannabis Cultivation Business Opportunities State-By-State

    Benzinga – 10:56 AM ET 07/28/2022

    Benzinga's Cannabis Insider is a live weekly show for cannabis and retail investors where we share with you the major cannabis news, stocks and exclusive interviews! Today's Guests: * Sara Gullickson, CEO - The Cannabis Business Advisors. * Jim Mish, CEO - 22nd Century Group.

  11. Show article details.

    22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022

    GlobeNewswire – 7:00 AM ET 07/27/2022

    22nd Century Group, Inc. (XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, will host a live webcast on Tuesday, August 9, 2022, at 10:00 AM ET to discuss its 2022 second quarter results, which are to be reported in a press release at 6:00 AM ET the same day.

  12. Show article details.

    Cannabis Stock Movers For July 22, 2022

    Benzinga – 5:45 PM ET 07/22/2022

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

  13. Show article details.

    [Video] GMO Cannabis? Gene Editing Vs. Breeding: The Eternal Debate

    Benzinga – 4:07 PM ET 07/21/2022

    Benzinga's Cannabis Insider is a live weekly show for cannabis and retail investors where we share with you the major cannabis news, stocks and exclusive interviews! Today's Guest: Meet The Hosts: Watch the full show here: https://www.youtube.com/watch?v=EDy5vEfdYd4&t=516s Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only.

  14. Show article details.

    22nd Century To Raise $35M Via Registered Direct Offering

    Benzinga – 10:32 AM ET 07/21/2022

    22nd Century Group, Inc. has entered into definitive agreements with institutional investors for the purchase and sale of 17.07 million shares of its common stock at a purchase price of $2.05 per share in a registered direct offering priced above market under Nasdaq rules.

  15. Show article details.

    Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

    Benzinga – 10:06 AM ET 07/21/2022

    According to Janney Montgomery Scott, the prior rating for Berkshire Hills Bancorp Inc was changed from Neutral to Buy. For Brixmor Property Group Inc, Mizuho upgraded the previous rating of Neutral to Buy. Loop Capital upgraded the previous rating for CSX Corp from Hold to Buy. Wells Fargo upgraded the previous rating for Las Vegas Sands Corp from Equal-Weight to Overweight.

  16. Show article details.

    22nd Century Group (Nasdaq: XXII) Strengthens Balance Sheet to Accelerate the Expansion of VLN Launch

    GlobeNewswire – 10:00 AM ET 07/21/2022

    22nd Century Group, Inc. (XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, announced that it has entered into definitive agreements with several institutional investors for the purchase and sale of 17,073,175 shares of its common stock at a purchase price of $2.05 per share in a r...

  17. Show article details.

    BRIEF-22Nd Century Announces $35 Million Registered Direct Offering Priced Above Market Under Nasdaq Rules

    Reuters – 9:32 AM ET 07/21/2022

    22nd Century Group Inc (XXII): * 22ND CENTURY ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED ABOVE MARKET UNDER NASDAQ RULES Source text for Eikon: Further company coverage:

  18. Show article details.

    22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules

    GlobeNewswire – 9:00 AM ET 07/21/2022

    22nd Century Group, Inc., leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 17,073,175 shares of its common stock at a purchase price of $2.05 per share in a regis...

  19. Show article details.

    Bullish Wednesday For Marijuana Stocks - Rhinomed, HEXO Among Top Gainers

    Benzinga – 4:35 PM ET 07/20/2022

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

  20. Show article details.

    Bullish Tuesday For Marijuana Stocks - Urban-gro, GrowGeneration Among Top Gainers

    Benzinga – 5:05 PM ET 07/19/2022

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

Page:

Today's and Upcoming Events

  • Nov
    02

    XXII to announce Q3 earnings (Unconfirmed)

Past Events (last 90 days)

  • Aug
    09

    XXII announced Q2 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.